The following article is a contribution to the topical collection “Recent Advances in Pharmacometabolomics: Enabling Tools for Precision Medicine” but was erroneously published in
Metabolomics
January 2017, 13:11
Pharmacometabolomic signature links simvastatin therapy and insulin resistance
Mona Elbadawi-Sidhu • Rebecca A. Baillie • Hongjie Zhu • Yii-Der Ida Chen • Mark O. Goodarzi • Jerome I. Rotter • Ronald M. Krauss • Oliver Fiehn • Rima Kaddurah-Daouk
Received: 10 July 2016 / Accepted: 26 November 2016 / Published online: 23 December 2016
Rights and permissions
About this article
Cite this article
Pharmacometabolomic signature links simvastatin therapy and insulin resistance: an addition to the topical collection “Recent Advances in Pharmacometabolomics: Enabling Tools for Precision Medicine”. Metabolomics 13, 57 (2017). https://doi.org/10.1007/s11306-017-1190-2
Published:
DOI: https://doi.org/10.1007/s11306-017-1190-2